Replimune Group, Inc. (REPL)

$12.14 -2.86% $-0.36 Healthcare

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

$829.59M

Mr. Philip Astley-Sparke F.S.A., FSA

206.00

Woburn, MA

Jul 20, 2018

-3.71

$-3.27

3.30

17.06

0.00%

-3.80

0.19

1.35

0.00

16.81

-30.13%

-35.52%

Similar stocks (11)

Nuvalent, Inc.

NUVL

$90.36 -4.27%
Neutral

Crinetics Pharmaceuticals, Inc.

CRNX

$58.78 -2.05%
Uptrend

Keros Therapeutics, Inc.

KROS

$66.70 -2.13%
Uptrend

Protagonist Therapeutics, Inc.

PTGX

$43.93 -5.53%
Uptrend

Kura Oncology, Inc.

KURA

$19.20 9.37%
Downtrend

PureTech Health plc

PRTC

$22.55 0.22%
Downtrend

Nuvectis Pharma, Inc.

NVCT

$10.64 -1.60%
Neutral

Gossamer Bio, Inc.

GOSS

$0.85 -1.21%
Downtrend

Aerovate Therapeutics, Inc.

AVTE

$2.66 1.14%
Downtrend

Kronos Bio, Inc.

KRON

$0.90 3.78%
Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.27 2.19%
Downtrend

ETF Exposure (23)

Loncar Cancer Immunotherapy ETF

CNCR

3.54%

$15.09 -4.12%
Neutral

Listed Funds Trust - Horizon Kinetics Medical ETF

MEDX

1.03%

$29.40 -0.54%
Downtrend

Invesco DWA Healthcare Momentum ETF

PTH

0.778%

$47.20 -1.91%
Uptrend

iShares Micro-Cap ETF

IWC

0.1747%

$135.90 -1.91%
Uptrend

Direxion Daily S&P Biotech Bull 3X Shares

LABU

0.1113034445%

$134.40 -6.91%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.083%

$23.77 -2.42%
Uptrend

iShares Biotechnology ETF

IBB

0.0625%

$144.36 -2.27%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.05298%

$177.58 -1.76%
Uptrend

Invesco FTSE RAFI US 1500 Small-Mid ETF

PRFZ

0.029%

$44.25 -1.54%
Uptrend

iShares Russell 2000 ETF

IWM

0.02598%

$237.36 -1.79%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.024971562725406543%

$62.76 -5.40%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

0.02207263%

$69.37 -1.28%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0177040065%

$27.60 -1.55%
Uptrend

Fidelity MSCI Health Care Index ETF

FHLC

0.00553722%

$70.21 -1.45%
Neutral

ALPS Medical Breakthroughs ETF

SBIO

0.0051%

$41.00 -3.37%
Uptrend

ProShares Hedge Replication ETF

HDG

0.004155508509720073%

$50.24 -0.58%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0.00135%

$131.55 -0.45%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

0.00125862%

$35.93 -0.53%
Uptrend

Dimensional U.S. Equity ETF

DFUS

0.0012584%

$65.17 -0.40%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

0.0010698284%

$23.18 -0.56%
Uptrend

iShares Russell 3000 ETF

IWV

8.2e-4%

$342.01 -0.45%
Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

7.9614e-4%

$59.32 -1.23%
Uptrend

Dimensional US Core Equity Market ETF

DFAU

5.062900000000001e-4%

$41.57 -0.38%
Uptrend